Standout Papers
- Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer (2015)
- A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY) (2021)
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study (2021)
- Molecular imaging in oncology: Current impact and future directions (2021)
- E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET (2021)
- Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2) (2023)
Immediate Impact
1 by Nobel laureates 7 from Science/Nature 61 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Steven P. Rowe being referenced
Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine
2020
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Steven P. Rowe | 5143 | 4275 | 1814 | 395 | 8.3k | |
| Ambros J. Beer | 3917 | 5616 | 1774 | 212 | 9.6k | |
| Anca-Ligia Grosu | 5201 | 4553 | 2134 | 408 | 11.0k | |
| Michael Flentje | 5105 | 4447 | 1913 | 370 | 11.4k | |
| Yuji Nakamoto | 2187 | 4008 | 1669 | 371 | 8.2k | |
| Gary Cook | 3813 | 6851 | 2787 | 313 | 10.8k | |
| Øyvind S. Bruland | 4100 | 3589 | 2866 | 239 | 8.1k | |
| Cynthia Ménard | 4134 | 2181 | 1313 | 207 | 6.9k | |
| Wolfgang P. Fendler | 5423 | 4885 | 2068 | 283 | 7.9k | |
| Gerhard Glatting | 2636 | 5011 | 1493 | 209 | 7.6k | |
| Heikki Minn | 2587 | 4088 | 1656 | 203 | 7.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...